Experts from the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care present insights and opinions on methods for treating refractory heart failure, genetically determined arrhythmias and atrial fibrillation in an integrated, multispecialty program.
|Innovating, Translating and Integrating Care in Clinical Electrophysiology
Wednesday, May 8, 2013
Innovating, Translating and Integrating Care in Clinical Electrophysiology will address evidence-based strategies that will impact your practice performance and improve outcomes for your patients with cardiovascular disease. The expert faculty will provide insights and opinions on methods for treating refractory heart failure, genetically determined arrhythmias and atrial fibrillation in an integrated, multispecialty program.
Jagmeet P. Singh, MD, PhD
Director, Resynchronization and Advanced Cardiac Therapeutics Program
Patrick T. Ellinor, MD, PhD
Director, Arrhythmia/Step Down Unit
Jose P. Garcia, MD
Surgical Director, Heart and Heart-Lung Transplantation and Mechanical Circulatory Support
Theofanie Mela, MD
Director, Pacer and ICD Lab
David J. Milan, MD
Associate Director, Cardiology Fellowship Program
Associate Director, Clinical Cardiac Electrophysiology Fellowship Program
MingMing Ning, MD
Co-Director, Cardio-Neurology Division
Director, Clinical Proteomics Research Center
Jeremy N. Ruskin, MD
Director, Cardiac Arrhythmia Service
Director, Clinical Cardiac Electrophysiology Fellowship Training Program
- Describe the role of novel LV lead implantation approaches, renal denervation, vagal nerve stimulators, autonomic modulation and ventricular assist devices to treat heart failure
- Discuss the potential of genotyping arrhythmias and individualizing treatment using stem cell strategies
- State the impact of clinical presentation, atrial electrophysiology, and atrial anatomy on the choice of appropriate ablation therapy for an individual patient with atrial fibrillation
- Evaluate the role of coordinated care for the management of atrial fibrillation and stroke
Resynchronization Therapy and Beyond
- Novel Electrophysiological Approaches to treat Non-Responders to Resynchronization Therapy
- Bolstering the Exhausted Heart: Advances in Assist Devices and Transplant
Bringing the Bench to the Bedside
- Clinical Phenotyping and Genotyping Arrhythmias in 2013
- Stem Cells and Electrophysiology: The Long QT Experiment
Atrial Fibrillation and the Next Frontier
- Electrophysiological Phenotypes and Catheter Ablation: Primary Electrical vs. Substrate-Based AF
- Stroke and the Heart: Using Multidisciplinary Approaches to Improve Clinical Outcome
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Massachusetts General Hospital. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.